Insider Shareholders with Direct Ownership of Prometheus Biosciences, Inc. (RXDX)
This section provides a comprehensive overview of the insiders with direct ownership of Prometheus Biosciences, Inc. (RXDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Prometheus Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sinai Medical Center Cedars
> 10% Shareholder |
4,416,008 | 0 | 5,008,508 $0 | 1 |
Mar 16, 2021
Added 6.73%
|
|
Mark Stenhouse
Chief Operating Officer |
23,811 | 26,754 | 26,442 $0 | 4 |
Dec 09, 2022
Added 27.06%
|
|
Joseph C Papa
Director |
17,278 | 17,278 | 17,278 $0 | 4 |
May 19, 2023
Added 11.65%
|
|
Tadataka Yamada
Director |
13,333 | 0 | 13,333 $0 | 1 |
Mar 16, 2021
Added 50.0%
|
|
Fred Hassan
Director |
2,123 | 2,123 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
Helen C. Adams
Director |
2,674 | 2,674 | 0 $0 | 3 |
Jun 16, 2023
Reduced 100.0%
|
|
Mary T Szela
Director |
2,071 | 2,071 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
Judith L Swain
Director |
2,071 | 2,071 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
James Laur
Director |
2,071 | 2,071 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
Martin Hendrix
Director |
2,071 | 2,071 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
Keith W Marshall
Chief Financial Officer |
117,973 | 117,973 | 0 $0 | 11 |
Jun 16, 2023
Reduced 100.0%
|
|
Mark C. Mc Kenna
Chairman, President and CEO |
300,044 | 303,098 | 0 $0 | 18 |
Jun 16, 2023
Reduced 100.0%
|